​

Verona Pharma Ownership | Who Owns Verona Pharma?

OverviewForecastRevenueFinancialsChartTranscripts

Verona Pharma Ownership Summary

Verona Pharma is owned by 3.34% institutional investors, 11.95% insiders, and 84.71% retail investors. Morgan stanley is the largest institutional shareholder, holding 1.07% of VRNA shares. Eventide Gilead N is the top mutual fund, with 2.22% of its assets in Verona Pharma shares.

VRNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVerona Pharma3.34%11.95%84.71%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley864.03K1.07%$12.49M
Perceptive advisors6.56M0.97%$416.71M
Nea management company5.58M0.86%$259.36M
Bank of america corp /de/611.02K0.76%$8.84M
Darwin global management3.92M0.58%$245.98M
Blackrock430.43K0.53%$6.22M
Frazier life sciences management3.46M0.51%$219.54M
Eventide asset management3.13M0.48%$145.46M
Maverick capital3.13M0.48%$145.29M
Wellington management group llp3.03M0.46%$140.49M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp1.44M19.04%$91.23M
Aisling capital management lp1.12M18.38%$51.80M
Darwin global management3.92M16.81%$245.98M
Perceptive advisors6.56M14.68%$416.71M
Nea management company5.58M14.64%$259.36M
Vivo capital2.28M11.88%$106.07M
Frazier life sciences management3.46M10.03%$219.54M
Artia global partners lp538.49K8.65%$34.19M
Alerce investment management88.00K7.19%$4.09M
Ctf capital management, lp236.77K6.22%$11.00M

Top Buyers

HolderShares% AssetsChange
Darwin global management3.92M16.81%3.11M
Wellington management group llp3.03M0.03%1.15M
Rtw investments, lp2.85M2.77%1.03M
Point72 asset management711.01K0.07%711.01K
Eventide asset management3.13M2.65%706.28K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---2.86M
Carlyle group---2.46M
Ra capital management---1.77M
Vivo capital2.28M11.88%-1.27M
Maverick capital3.13M2.61%-1.09M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management711.01K0.07%711.01K$33.02M
Ctf capital management, lp236.77K6.22%236.77K$11.00M
Gw&k investment management232.35K0.09%232.35K$10.79M
Baker bros. advisors lp223.84K0.16%223.84K$14.21M
Balyasny asset management183.90K0.01%183.90K$8.54M

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-2.00
Naples money management-100.00
National bank of canada /fi/-150.00
Redwood wealth management group-410.00
Quarry lp-2.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202525-88.37%22,667,271-66.98%33.01%15-86.96%5-92.06%
Dec 31, 202420123.31%61,094,145-9.72%90.14%10623.26%6122.00%
Sep 30, 202416121.97%67,432,1272.42%821.25%8519.72%4948.48%
Jun 30, 202413111.97%65,836,577-1.14%811.16%7018.64%3322.22%
Mar 31, 2024117-4.88%66,592,785-1.29%8475.18%59-4.84%27-6.90%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Gilead N1.89M2.22%472.89K
T. Rowe Price Health Sciences1.37M1.61%-142.36K
Eventide Healthcare & Life Sciences I1.23M1.45%227.47K
Bellevue Healthcare Ord1.10M1.36%1.10M
Hood River Small-Cap Growth Instl838.91K0.99%-
Federated Hermes Kaufmann Small Cap A777.40K0.91%-161.10K
Federated Hermes Kaufmann Small Cap Grow777.40K0.91%-161.10K
Janus Henderson Glb Life Scn I2 USD766.18K0.90%146.41K
Janus Henderson Global Life Sciences761.59K0.89%761.59K
Janus Henderson Global Life Sciences D761.59K0.89%232.24K

Recent Insider Transactions

DateNameRoleActivityValue
May 27, 2025Hahn Mark W Chief Financial OfficerSell$308.98K
May 28, 2025Hahn Mark W Chief Financial OfficerSell$1.51M
May 29, 2025Hahn Mark W Chief Financial OfficerSell$1.91M
May 27, 2025ZACCARDELLI DAVID President and CEOSell$320.18K
May 28, 2025ZACCARDELLI DAVID President and CEOSell$1.47M

Insider Transactions Trends

DateBuySell
2025 Q2-23
2025 Q1-1
2024 Q4333
2024 Q318
2024 Q2-1

VRNA Ownership FAQ

Who Owns Verona Pharma?

Verona Pharma shareholders are primarily institutional investors at 3.34%, followed by 11.95% insiders and 84.71% retail investors. The average institutional ownership in Verona Pharma's industry, Biotech Stocks , is 63.97%, which Verona Pharma falls below.

Who owns the most shares of Verona Pharma?

Verona Pharma’s largest shareholders are Morgan stanley (864.03K shares, 1.07%), Perceptive advisors (6.56M shares, 0.97%), and Nea management company (5.58M shares, 0.86%). Together, they hold 2.89% of Verona Pharma’s total shares outstanding.

Does Blackrock own Verona Pharma?

Yes, BlackRock owns 0.53% of Verona Pharma, totaling 430.43K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.22M$. In the last quarter, BlackRock increased its holdings by 48.71K shares, a 12.76% change.

Who is Verona Pharma’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Verona Pharma’s biggest shareholder by percentage of total assets invested, with 19.04% of its assets in 1.44M Verona Pharma shares, valued at 91.23M$.

Who is the top mutual fund holder of Verona Pharma shares?

Eventide Gilead N is the top mutual fund holder of Verona Pharma shares, with 2.22% of its total shares outstanding invested in 1.89M Verona Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools